Swiss drug major Roche Group (RHHBY) reported Thursday that its fiscal 2019 IFRS net income rose 30% to 14.11 billion Swiss francs from last year's 10.87 billion francs, reflecting strong underlying operating results and the base effect of high goodwill impairments in 2018.
from RTT - Earnings https://ift.tt/314jjNX
via IFTTT
No comments:
Post a Comment